Levetiracetam improves intention tremor in fragile x-associated tremor/ataxia syndrome

Clinical Neuropharmacology

Volumn 32, Issue 1, 2009, Pages 53-54

  Saponara, Riccardo ^a,c   Greco, Salvatore ^a   Proto, Giuliana ^a   Trubia, Teresa ^a   Domina, Elisabetta ^b  

^a Neurological Unit Private Hospital   (Italy)

^b Neurorehabilitation Unit   (Italy)

^c Unità Funzionale di Neurologia   (Italy)

Author keywords

Fragile X; FXTAS; Levetiracetam; Tremor

Indexed keywords

ETIRACETAM;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FMR1 GENE; FRAGILE X SYNDROME; GENE; HAND TREMOR; HUMAN; MALE; PRIORITY JOURNAL; WRITING;

AGED; ANTICONVULSANTS; ATAXIA; FAMILY HEALTH; FRAGILE X SYNDROME; HUMANS; MALE; PIRACETAM; TREMOR;

EID: 67749106394     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31816a48e2     Document Type: Article

References (8)

1. Hangerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001;57:127-130.
2. Leppik IE, Biton V, Sander JW, et al. Levetiracetam and partial seizures subtypes: pooled data from three randomized, placebo controlled trials. Epilepsia 2003; 44:1585-1587.
3. Striano P, Manganelli F, Boccella P, et al. Levetiracetam in patients with cortical myoclonus: a clinical electrophysiological study. Mov Disord 2005;20:1610-1614.
4. Hall DA, Berry-Kravis E, Hagerman RJ, et al. Symptomatic treatment in the fragile X associated tremor ataxia syndrome. Mov Disord 2006;21:1741-1744.
5. Bourgelois JA, Farzin F, Brumberg JA, et al. Dementia with mood symptoms in fragile X premutation carrier with the fragile X associated tremor ataxia syndrome: clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci 2006; 18: 171-177.
6. Elble RJ, Lyons KE, Pahwa R. Levetiracetam is not effective for essential tremor. Clin Neuropharmacol 2007;30(6):350-356.
7. Ondo WG, Jimenez JE, Vuong KD, et al. An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol 2004;274-277.
8. Striano P, Coppola A, Vacca G, et al. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. J Neurol 2006;253:762-766.